Twitter Inc (TWTR): The Work Gets Harder From Here
BMO Capital analyst Daniel Salmon is out today with a research note on shares of Twitter Inc …
NXT-ID Inc (NXTD) Stock Can Reach $6: Brian Kinstlinger
Maxim’s Brian Kinstlinger: The recent capital raise is a significant positive event for NXTD.
Teva Pharmaceutical Industries Gets FDA Priority Review for Fremanezumab, Putting It a Month Behind Amgen in Race for Migraine Market
Teva Pharmaceutical Industries Ltd (ADR) (NYSE:TEVA) has secured a priority review at the FDA for …
Roku Inc (ROKU) 3Q Earnings Give This Top Analyst a Bit More Confidence
Mark Mahaney believes the company is executing on its long-term vision, but remains sidelined.
Top Analyst Pounds the Table on Activision Blizzard, Inc. (ATVI)
Piper Jaffray’s top analyst Michael Olson was out pounding the table on shares of Activision Blizzard, …
Alibaba Group Holding Ltd (BABA) Nailed It Again; Top Analyst Reiterates Buy
Alibaba Group Holding Ltd (NYSE:BABA) reported another strong set of headline earnings, with results well …
Maxim Reiterates Buy On ContraVir Pharmaceuticals Inc (CTRV) Following Corporate Update
Maxim analyst Jason Kolbert is out today with a new research note on shares of ContraVir Pharmaceuticals …
How Analysts View Netflix, Inc. (NFLX) Post 3Q:17 Results
In a research note released Tuesday, Aegis analyst Victor Anthony reiterated a Hold rating on …
Cantor Pounds the Table on Valeant Pharmaceuticals Intl Inc (VRX)
Fears about financial control should be a buying opportunity in Valeant stock, says Cantor.
Maxim Pounds the Table on MannKind Corporation (MNKD)
Will Mannkind file bankruptcy? Jason Kolbert says no.